MedTrace Logo

Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy

NCT01287286 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2011-02-08

No results posted yet for this study

Summary

The purpose of this study is to investigate if food supplements,Antrodia cinnamomea, could minimize the gastrointestinal symptom of cancer patients with chemotherapy.

Conditions

  • Neoplasm
  • Functional Gastrointestinal Disorder

Interventions

DIETARY_SUPPLEMENT

AC-Can

Antrodia cinnamomea compounds of 15 milliliters liquid per pack, oral post meal, twice in a day for 30 days

DIETARY_SUPPLEMENT

placebo

Placebo of 15 milliliters liquid per pack, oral post meal, twice in a day for 30 days

Sponsors & Collaborators

  • New Bellus Enterprises

    collaborator UNKNOWN

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Yu-Chiang Hung, MD, PhD · Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital - Kaohsiung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-04-30
Completion
2012-05-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01287286 on ClinicalTrials.gov